David Hallal
CIK 1457477 · Chief Executive Officer · last filed 2026-06-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$82.08M
Companies
5
Total Filings
112
Lifetime Open-Market Net
-$16.84M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KLRS | Director | — | $4.33 | — | $0 | 2 | 2026-06-04 |
| SRRK | Chief Executive Officer | 1,844,034 | $44.18 | $81.47M | -$3.97M | 15 | 2026-04-20 |
| iTeos Therapeutics, Inc. (ITOS) Delisted | Director | 0 | $10.15 | $0 | -$3.94M | 9 | 2025-08-29 |
| SEER | Director | 355,128 | $1.72 | $610.8K | $0 | 5 | 2024-06-14 |
| Kalaris Therapeutics, Inc. (ALVR) Delisted | Director | 2,281,815 | $9.81 | $22.38M | -$8.93M | 15 | 2024-06-07 |
Recent Filings · Page 3 of 12
112 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-08-01 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Grant (A) | +3,253,796 | $15.00M | EDGAR |
| 2022-07-21 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Sell (S) | −4,227 | -$22.5K | EDGAR |
| 2022-06-21 | SRRK | Grant (A) | — | $0 | EDGAR |
| 2022-06-17 | SEER | Grant (A) | +9,945 | $0 | EDGAR |
| 2022-06-10 | iTeos Therapeutics, Inc. (ITOS) Delisted | Mixed | — | -$487.2K | EDGAR |
| 2022-06-06 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Sell (S) | −65,725 | -$241.1K | EDGAR |
| 2022-05-27 | SRRK | Grant (A) | — | $0 | EDGAR |
| 2022-05-19 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-22 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Sell (S) | −4,227 | -$24.8K | EDGAR |
| 2022-03-11 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Sell (S) | −65,725 | -$491.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.